An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection.

To first explore the prognostic value of MMP11 and MMP15 in hepatocellular carcinoma. MMP11/MMP15 expression was immunohistochemically detected and correlated with clinicopathologic variables and survival and confirmed in publicly available databases. An MMP-based risk score (MMPRS) was established. Tumoral MMP11/MMP15 expression was higher and univariately associated with crucial clinicopathologic parameters, overall survival and disease-free survival in all patients and/or many subsets. Multivariately, MMP11/MMP15 expression remained significant. Their overexpression and prognostic value were confirmed in the Ualcan and Kaplan-Meier plotter databases. Critically, the novel MMPRS integrating MMP11, MMP15 and tumor-node-metastasis stage identified subgroups with the best and worst prognoses, with much higher predictive power. MMP11 and MMP15 served as prognosticators in hepatocellular carcinoma. MMPRS might work more accurately.